The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis
Tissue and Cell · 2026
DOI: 10.1016/j.tice.2026.103702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tissue and Cell, 2026. Verfasst von Congcong Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hos…. Hauptthemen laut MEDLINE: Macrophages, Fibrosis, Myofibroblasts. Die Arbeit nennt 104 Literaturangaben. Gefördert von: Shandong First Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Fibrotic repair is an innate protective mechanism activated following tissue injuries to promote structural stability and adaptability. However, when this process persists beyond appropriate temporal and spatial limits, it becomes pathological, culminating in irreversible cellular damage and organ dysfunction-similar to a sponge losing its flexibility due to excessive adhesions. These pathological alterations fundamentally rely on myofibroblast-mediated intercellular transition and the accumulation of extracellular matrix (ECM). Increasing evidence indicates that myofibroblasts can originate from multiple cellular sources, with macrophage-myofibroblast transition (MMT) as a key factor. MMT significantly impacts fibrotic processes in the liver, heart, kidneys, and lungs, with emerging evidence in skeletal muscle, involving several molecular signaling pathways including TGF-β/Smad3, ALKBH5/IL-11, Src kinase, and Jmjd3/IRF4 axes. Organ-specific molecular pathways provide precision therapeutic targets for clinical intervention. This review consolidates current findings into the mechanistic roles of MMT in the progression of fibrosis across different organs, highlighting that therapeutically targeting MMT represents a promising strategy for reversing fibrosis and restoring the function of affected organs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China. Electronic address: xiaonverzeiguai@163…
- School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
- Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical, University & Shandong Provincial…
- Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong First Medical University, Shandong Key Laboratory of R…
- Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Förderung
- Shandong First Medical University
- National Natural Science Foundation of China
Zitieren
APA
Guo, C., Cao, R., Liao, L., Zhao, J., Wang, T., Li, J., Zhang, Y., & Li, H. (2026). The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis. Tissue and Cell. https://doi.org/10.1016/j.tice.2026.103702
Vancouver
Guo C, Cao R, Liao L, Zhao J, Wang T, Li J, et al. The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis. Tissue and Cell. 2026. doi:10.1016/j.tice.2026.103702
BibTeX
@article{Guo2026,
author = {Guo, Congcong and Cao, Ran and Liao, Lin and Zhao, Junyu and Wang, Tianzuo and Li, Junhan and Zhang, Yue and Li, Haotian},
title = {The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis},
journal = {Tissue and Cell},
year = {2026},
doi = {10.1016/j.tice.2026.103702}
}
EUVIMED